|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Phase II Study of Everolimus in Patients with Metastatic Colorectal Adenocarcinoma Previously Treated with Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regimens显示文摘 | Kimmie Ng Josep Tabernero Jimmy Hwang Emilio Bajetta Sunil Sharma Salvatore A. Del Prete Edward R. Arrowsmith David P. Ryan Michaela Sedova Jin Jin Kamel Malek Charles S. Fuchs | 2013 | Clinical Cancer Research2013，，14： | 4 |
| 2 | Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?显示文摘 | Emilio Bajetta Laura Catena Giuseppe Procopio Sara Dosso Ettore Bichisao Leonardo Ferrari Antonia Martinetti Marco Platania Elena Verzoni Barbara Formisano Roberto Bajetta | 2007 | Cancer Chemotherapy and Pharmacology2007，，： | 2 |
| 3 | Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial显示文摘 | Bernard Escudier Anna Pluzanska Piotr Koralewski Alain Ravaud Sergio Bracarda Cezary Szczylik Christine Chevreau Marek Filipek Bohuslav Melichar Emilio Bajetta Vera Gorbunova Jacques-Olivier Bay Istvan Bodrogi Agnieszka Jagiello-Gruszfeld Nicola Moore | 2007 | The Lancet . 2007 (9605)2007，，： | 2 |
| 4 | Phase 3 trial of octreotide pamoate(OPLAR) and tamoxifen in metastatic breast cancer显示文摘 | Bajetta E Sommer H Guastalla J | 1999 | Proc ASCO1999，18，3： | 1 |
| 5 | Adjuvant chemotherapy in gastriccancer: 5-year results of a randomized study by the Italian TrialsinMedical On- cology (ITMO) Group 显示文摘 | Bajetta E Buzzoni R Mariani L | 2002 | Ann Oncol2002，13，2： | 1 |
| 6 | Phase Ⅱ study of the etoposide,leucovorin and fluorouracil combination for patients with advanced gastric cancer unsuitable for aggressive chemotherapy显示文摘 | Di Bartolomeo M Bajetta E de Braud F | 1995 | Oncology1995，52，： | 1 |
| 7 | Activity of exemestate in metastatic breast cancer after failure of nonsteroidal aromatase inhibitorsa phase Ⅱ tril显示文摘 | Linning PE Bajetta E Munay R | 2005 | J Clin Oncol2005，18，11： | 1 |
| 8 | Renal cell cancer andsorafenib : skin toxicity and treatment outcome 显示文摘 | Bajetta E Procopio G Verzoni E | 2007 | Tumori2007，93，2： | 1 |
| 9 | Comparison of immunofluorescent findings in kidney after snap-freezing and formalin fixation显示文摘 | Fogazzi G B Bajetta M Banfi G | 1989 | Pathol Res Pract1989，185，2： | 1 |
| 10 | Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer:, resuits of a phase Ⅲ randomized double-blind trial 显示文摘 | Kaufmann M Bajetta E Dirix LY | 2000 | J Clin Oncol2000，18，7： | 1 |
| 11 | Randomized trail of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectalcancer显示文摘 | Rougier P Cutsem E V Bajetta E | 1998 | Lancet1998，352，： | 1 |
| 12 | Effect of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving non platinum chemotherapy:results of a randomized,double-blind,place-bocont rolledtrial显示文摘 | Littlewood TJ Bajetta E Nortier JWR | 2001 | J Clin Oncol2001，19，11： | 1 |
| 13 | Ten-year suvival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus显示文摘 | Bidoli P Bajetta E Stani S C | 2002 | Cancer2002，94，2： | 1 |
| 14 | Phaes U study of pemetrexed disodium (Alimta) administered with oral folic acid in patients with advanced gastric cancer 显示文摘 | Bajetta E Celio L Buzzoni R | 2003 | Ann Oncol2003，14，10： | 1 |
| 15 | Final results of CONFIRM2: A multinational, randomized, doubleblind, phase Ⅲ study in 2nd line patients(pts) with emetastatic colorectal cancer(mCRC) receiving FOLFOX4 and PTK787/ZK222584(PTK/ZK) orplaeebo显示文摘 | Kohne C Bajetta E Lin E | 2007 | J Clin Oncol2007，25，18： | 1 |
| 16 | Activity of exemestane in me-tastatic breast cancer after failure of nonsteroidal aromatase inhibitors:a phase Ⅱ trial显示文摘 | Lonning PE Bajetta E Murray R | 2000 | J Clin Oncol2000，18，11： | 1 |
| 17 | Ovarian ablation for premenopausal early-stage breast cancer:an update显示文摘 | Celio L Bajetta E Toffolatti L | 2000 | Tumori2000，86，3： | 1 |
| 18 | Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer 显示文摘 | Rougier P Van Cutsem E Bajetta E | 1998 | Lancet1998，352，9138： | 1 |
| 19 | Raltitrexed plus oxaliplatin in the treatment of metastatic colorectal cancer 显示文摘 | Cortinovis D Bajetta E Di Bartolomeo M | 2004 | Tumori2004，90，2： | 1 |
| 20 | Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors: a phase Ⅱ trial显示文摘 | Lφnning PE Bajetta E Murray R | 2000 | J Clin Oncol2000，18，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员